Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...

Texas Children's Hospital in Austin performs fetal blood transfusion to save the life of baby exposed to childhood illness.

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...

As the global population ages, 2025 has delivered a remarkable wave of new research aimed at supporting healthier brains in ...

Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 -- Affecting up to 100,000 people in the U.S. and up to 5.6 ...

The national government plans to borrow more than P800 billion from the domestic market in the first quarter of next year, ...

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an accep ...

Specialization beats scale when volume is low, priorities shift quickly and you're still learning what the role should become ...

The Baptist Heart Institute has performed nearly 500 heart transplants since its founding. A recipient said the group was "full of miracle workers." ...

A 62-year-old Bengaluru resident, Sanjay Kumar Gupta, experienced a remarkable 90% improvement in mobility and daily function ...